To determine whether clopidogrel with aspirin (C+ASA) will produce more potent platelet inhibition than aspirin alone (ASA) in patients after ischemic stroke.
- Aspirin (stroke prevention) Drug
Intervention Desc: Antiplatelet agent; inhibits thromboxane A2
- Clopidogrel (Plavix®)Drug
Other Names: Plavix, Clodelib, Clovelen Intervention Desc: Antiplatelet agent
Randomized, controlled, antiplatelet trial.
All patients were treated with 81 mg aspirin for at least 1 month before enrollment and were randomly assigned to one of the two groups: C+ASA (75 mg clopidogrel + 81 mg aspirin) or ASA (81 mg.). Patients received platelet tests at baseline and after 30 days after randomization.
|Type||Measure||Time Frame||Safety Issue|
|Primary||Platelet tests given to all patients at baseline and after 30 days after randomization.|